Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Mirella Ezban"'
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1493-1502
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3248ecdcc4963cd4b43ca67a9ed61e0f
https://doi.org/10.1016/j.jtha.2023.03.007
https://doi.org/10.1016/j.jtha.2023.03.007
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:480-487
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c012dd633a24b87e510a13eca427ff27
https://doi.org/10.1016/j.jtha.2022.12.023
https://doi.org/10.1016/j.jtha.2022.12.023
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 31:334-339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff3c4f201c719856a701bb2c598871f
https://doi.org/10.2491/jjsth.31.334
https://doi.org/10.2491/jjsth.31.334
Publikováno v:
Haemophilia
Factor replacement therapy with factor VIII (FVIII) concentrates is the current standard of care for patients with haemophilia A. Postadministration monitoring of FVIII activity during on‐demand or prophylactic treatment is important, for example t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e6922616a407b147e7c78282157b30
https://doi.org/10.1111/hae.13897
https://doi.org/10.1111/hae.13897
Publikováno v:
Acta Haematologica. 143:504-508
N8-GP (ESPEROCT®; turoctocog alfa pegol; Novo Nordisk A/S, Bagsvaerd, Denmark) is an extended half-life recombinant factor VIII (FVIII) molecule. FVIII-deficient plasma spiked with N8-GP can be accurately measured using many activated partial thromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc2b538cafe24c4ea3feed98a4cf4f94
https://doi.org/10.1159/000503377
https://doi.org/10.1159/000503377
Publikováno v:
Haemophilia
Aim N8‐GP (turoctocog alfa pegol) is a glycoPEGylated, extended half‐life human recombinant factor VIII (FVIII) shown to be an efficacious treatment for patients with haemophilia A. Accurate monitoring of replacement therapy helps ensure proper d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9b695a6f4909e7df9a2895347cb984
http://europepmc.org/articles/PMC6852407
http://europepmc.org/articles/PMC6852407
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 30:733-741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15a5ad4158a1d655fc83ba3414a8c9e7
https://doi.org/10.2491/jjsth.30.733
https://doi.org/10.2491/jjsth.30.733
Publikováno v:
Haemophilia. 27
FVIII activity in samples taken at various time points from 21 patients treated with N8-GP (Esperoct® ; turoctocog alfa pegol) during the pathfinder clinical trial programme was assessed and compared using different assay methods. FVIII activity mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97eb08c7bec61f46be73096f5bee8796
https://doi.org/10.1111/hae.14173
https://doi.org/10.1111/hae.14173
Publikováno v:
Journal of Thrombosis and Haemostasis. 16:1817-1829
Essentials Factor VIIa binds activated platelets to promote hemostasis in hemophilia patients with inhibitors. The interactions and sites responsible for platelet-FVIIa binding are not fully understood. Endothelial cell protein C receptor (EPCR) is e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb41a5c3502c1618343279ca81937b02
https://doi.org/10.1111/jth.14165
https://doi.org/10.1111/jth.14165
Autor:
Erika J. Martin, Melinda E Nolte, Bassem M. Mohammed, Marisa Ninivaggi, John C. Barrett, Emily K. Waters, Janice Kuhn, Donald F. Brophy, Mirella Ezban
Publikováno v:
Haemophilia. 24:815-822
INTRODUCTION The thrombin generation assay (TGA) can be used to monitor factor replacement therapy in patients with haemophilia. The TGA assay is typically performed using tissue factor as the reaction activator; however, activating with FIXa or FXIa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10692feb42d0df92b3f91edf8909c805
https://doi.org/10.1111/hae.13597
https://doi.org/10.1111/hae.13597